Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tangshan Likang Pharmaceutical is a prominent Chinese pharmaceutical manufacturer specializing in the production of antipyretic and analgesic medications. The company is globally recognized as one of the largest production bases for Paracetamol (Acetaminophen) active pharmaceutical ingredients (APIs) and finished dosage forms. Based in Tangshan, Hebei Province, it operates large-scale, GMP-certified manufacturing facilities that supply both domestic and international markets. Its core business focuses on high-volume chemical synthesis and the production of essential medicines for pain and fever management. In addition to Paracetamol, the company produces other pharmaceutical intermediates and finished drugs such as Aspirin.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tangshan Likang Pharmaceutical.